Literature DB >> 14408392

Blocking the renal electrolyte effects of mineralocorticoids with an orally active steroidal spirolactone.

C M KAGAWA.   

Abstract

Entities:  

Keywords:  ADRENAL CORTEX HORMONES/pharmacology; LACTONES/pharmacology

Mesh：

Substances：

Year:  1960        PMID： 14408392     DOI： 10.1210/endo-67-1-125

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  20 in total

1.  The actions of a spirolactone and two related compounds in hypophysectomized rats.

Authors:  M F LOCKETT; C N ROBERTS
Journal:  J Physiol       Date:  1963-07       Impact factor: 5.182

2.  Bioassay of aldosterone antagonists in normal human subjects: a relationship between the level of plasma uric acid before treatment and apparent drug responses.

Authors:  L E Ramsay; P Hessian; M J Tidd
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

3.  Canrenoate disposition in dogs. Tissue distribution and elimination.

Authors:  J Kuhlmann; V Kötter; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-06       Impact factor: 3.000

4.  Canrenone--the principal active metabolite of spironolactone?

Authors:  L E Ramsay; J R Shelton; D Wilkinson; M J Tidd
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

5.  Conversion of spironolactone to canrenone and disposition kinetics of spironolactone and canrenoate-potassium in rats.

Authors:  W Sadée; U Abshagen; C Finn; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

Review 6.  Corticosteroid receptor antagonists: a current perspective.

Authors:  W Sutanto; E R de Kloet
Journal:  Pharm World Sci       Date:  1995-03-24

7.  Relative potency and structure activity relationships of aldosterone antagonists in healthy man: correlation with animal experience.

Authors:  G T McInnes; J R Shelton; L E Ramsay; I R Harrison; M J Asbury; J M Clarke; R M Perkins; G R Venning
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

8.  Spironolactone dose-response relationships in healthy subjects.

Authors:  G T McInnes; R M Perkins; J R Shelton; I R Harrison
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

9.  Antagonism of endogenous mineralocorticoids in normal subjects by prorenoate potassium and spironolactone.

Authors:  D Levine; L Ramsay; R Auty; R Branch; M Tidd
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

10.  Aldosterone on sodium transport of rat distal colon in long-term adrenalectomy during acute and chronic substitution.

Authors:  M Horster; A Lückhoff
Journal:  J Physiol       Date:  1983-07       Impact factor: 5.182
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.